Pacira BioSciences (PCRX) Long-Term Investments (2016 - 2023)
Historic Long-Term Investments for Pacira BioSciences (PCRX) over the last 10 years, with Q4 2023 value amounting to $2.4 million.
- Pacira BioSciences' Long-Term Investments fell 9352.31% to $2.4 million in Q4 2023 from the same period last year, while for Dec 2023 it was $2.4 million, marking a year-over-year decrease of 9352.31%. This contributed to the annual value of $2.4 million for FY2023, which is 9352.31% down from last year.
- According to the latest figures from Q4 2023, Pacira BioSciences' Long-Term Investments is $2.4 million, which was down 9352.31% from $8.3 million recorded in Q1 2023.
- In the past 5 years, Pacira BioSciences' Long-Term Investments registered a high of $95.5 million during Q4 2020, and its lowest value of $2.4 million during Q4 2023.
- Its 5-year average for Long-Term Investments is $37.0 million, with a median of $35.0 million in 2020.
- Per our database at Business Quant, Pacira BioSciences' Long-Term Investments surged by 148413.49% in 2019 and then crashed by 9352.31% in 2023.
- Over the past 5 years, Pacira BioSciences' Long-Term Investments (Quarter) stood at $64.8 million in 2019, then skyrocketed by 47.32% to $95.5 million in 2020, then plummeted by 63.37% to $35.0 million in 2021, then grew by 6.4% to $37.2 million in 2022, then plummeted by 93.52% to $2.4 million in 2023.
- Its Long-Term Investments stands at $2.4 million for Q4 2023, versus $8.3 million for Q1 2023 and $37.2 million for Q4 2022.